Quinolines as FGFR kinase modulators
US9439896B2 · kind B2 · utility
23Cited by
17References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 26, 2012 |
| Grant date | Sep 13, 2016 |
| Priority date | — |
| Expiry date | Oct 26, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to new quinoline derivative compounds of formula (I), to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer. Formula (I)
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.